HSTM
HEALTHSTREAM INC
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$32.51
+2.64%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 328.0M | 304.1M | 291.6M | 279.1M | 266.8M |
| Cost of Revenue | 115.6M | 107.2M | 97.9M | 95.0M | 91.1M |
| Gross Profit | 212.3M | 196.9M | 193.7M | 184.0M | 175.7M |
| Operating Expenses | |||||
| R&D Expense | 55.5M | 51.0M | 48.9M | 45.5M | 44.3M |
| SG&A Expense | 87.1M | 82.2M | 82.3M | 81.4M | 81.0M |
| General & Admin Expense | 34.0M | 32.8M | 35.1M | 35.7M | 36.9M |
| Selling & Marketing Expense | 53.1M | 49.4M | 47.2M | 45.7M | 44.1M |
| Other Expenses | 44.9M | 43.5M | 41.2M | 41.1M | 37.9M |
| Total Operating Expenses | 187.5M | 176.6M | 172.4M | 168.0M | 163.2M |
| Cost and Expenses | 303.1M | 283.8M | 270.4M | 263.0M | 254.4M |
| Operating Income (EBIT) | 24.8M | 20.2M | 21.3M | 16.0M | 12.4M |
| Non-Operating | |||||
| Interest Income | 2.1M | 3.3M | 3.8M | 2.4M | 444.0K |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | 2.1M | 3.3M | 3.8M | 2.4M | 444.0K |
| Other Non-Op Income/Expense | 1.6M | 3.0M | 3.5M | 2.5M | 3.1M |
| Non-Operating Income (excl Interest) | (1.2M) | (3.0M) | (3.5M) | (2.5M) | (3.1M) |
| EBT (Pre-Tax Income) | 26.4M | 23.2M | 24.8M | 18.5M | 15.6M |
| Income Tax Expense | 6.0M | 4.9M | 4.8M | 3.3M | 3.5M |
| Bottom Line | |||||
| Net Income | 20.5M | 18.3M | 20.0M | 15.2M | 12.1M |
| Earnings from Cont. Ops | 20.5M | 18.3M | 20.0M | 15.2M | 12.1M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 20.5M | 18.3M | 20.0M | 15.2M | 12.1M |
| Per Share | |||||
| Basic EPS | $0.70 | $0.61 | $0.66 | $0.50 | $0.39 |
| Diluted EPS | $0.70 | $0.61 | $0.66 | $0.50 | $0.39 |
| Revenue Per Share | $11.12 | $10.13 | $9.60 | $9.13 | $8.71 |
| Shares | |||||
| Basic Shares Outstanding | 29.5M | 30.0M | 30.4M | 30.6M | 30.6M |
| Diluted Shares Outstanding | 29.7M | 30.1M | 30.5M | 30.7M | 30.7M |
| Profitability Metrics | |||||
| EBITDA | 71.0M | 66.7M | 66.0M | 59.6M | 53.5M |
| D&A | 44.9M | 43.5M | 41.2M | 41.1M | 37.9M |
| EBIT | 26.1M | 23.2M | 24.8M | 18.5M | 15.6M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026